Morphic Therapeutic
MORF
$27.77
Share price
0.29%
Change (1 day)
-36.20%
Change (1 year)
Categories
Revenue for Morphic Therapeutic (MORF)
Revenue in 2023 (TTM): $0.52 M
According to Morphic Therapeutic's latest financial reports the company's current revenue (TTM) is $0.52 M. In 2022 the company made a revenue of $70.8 M an increase over the years 2021 revenue that were of $19.79 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Morphic Therapeutic from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.52 M | -99.26% |
| 2022 | $70.8 M | 257.74% |
| 2021 | $19.79 M | -55.96% |
| 2020 | $44.94 M | 164.76% |
| 2019 | $16.97 M | 405.54% |
| 2018 | $3.35 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | 165,637.81% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -56.62% | 🇺🇸 USA |